+
Site Tour

EACTS 2021: EACTS/ESC MVR Guidelines update and implications: Introduction (Treatment Options for Secondary Mitral Regurgitation)

Hans-Joachim Schäfers
Introduction to symposium "Mitral Valve Replacement in the Current Era: New Guidelines and Considerations to Tailor the Treatment to Every Patient"

Related Videos

TAVI Summit - Cardiac imaging and morphology

TAVI Summit 2023: Morphology

AV VALVES 2023:Decision Making in HF – Mitral

Webinar: Aortic & Mitral Valve Disease

PremiClose 2024: Neo-Ped Cardio Team

Now you've got Navitor.
Future ready.

TriClip™: Device features

PCRLV 2022: TAVI Hemodynamic performance

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

PCR LV 2021: Navitor™ 30-day outcomes

PCR LV 2021: Navitor™ Looking ahead

PCRLV 2022: bRIGHT 30 days

EuroPCR 2022: TAVI 1yr outcomes

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023:HF and VHD – Patient Management

AV VALVES 2023: MR – Mixed MR

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

Now you've got Navitor.
Future ready.

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline